north40000
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMRN | Amarin Corp. PLC ADS | 1.41 | -0.08 | -5.37% | 03/03/2021 | |||||
| GILD | Gilead Sciences, Inc. | 62.36 | 0.55 | 0.89% | 05/02/2018 | |||||
|
My GILD Pitch: Our basis is split-adjusted $0.758/share, acquired 06-1996.GILD's Focus is on treatments for HIV, HCV, HBV, Oncology, future acquisitions. http://tinyurl.com/jva7ron; http://www.gilead.com/
https://tinyurl.com/ya7oeqms |
||||||||||
| VCEL | Vericel Corp. | 25.82 | 0.64 | 2.54% | 04/12/2018 | |||||
| CDMO | Avid Bioservices Inc. | 15.33 | 0.07 | 0.46% | 01/15/2018 | |||||
|
My CDMO Pitch: http://ih.advfn.com/p.php?pid=nmona&article=55726349
http://www.peregrineinc.com/images/stories/pdfs/2013_asco_breast.pdf 2016 ASM:http://tinyurl.com/z3nv3g9 AACR 2017: http://tinyurl.com/jxfm3hb Exosome studies; Cancer diagnostic:https://tinyurl.com/yd3n5kbk https://tinyurl.com/ya6tgxxa |
||||||||||
| WFM | Whole Foods Markets | 11/11/2017 | ||||||||
|
My WFM Pitch: We have shopped for groceries at WFM for many years. We like its quality--if you like the company's product chances are you should buy its stock. Our split-adjusted basis is $17.37. AMZN purchased WFM for $42/share in 2017.
|
||||||||||
| Ariad Pharmaceuticals Inc (fka ARIA) | 02/15/2017 | |||||||||
|
My Pitch: Our basis is $2.29. I am confident of share price increase predicated on upcoming catalysts at FDA, recent financing and potential buy-out. Doubled holdings on 11/07/2013. Takeda agrees to acquire ARIA: $24/share
http://tinyurl.com/jrahcmc |
||||||||||
| Ocata Therapeutics Inc. (fka OCAT) | 03/04/2016 | |||||||||
|
My Pitch: http://tinyurl.com/gsvoj2l
http://tinyurl.com/luke478 http://tinyurl.com/n6zc5dd http://tinyurl.com/mvk6ul4 http://www.futuremedicine.com/doi/pdf/10.2217/rme.14.89 http://stemcellassays.com/2015/03/products-pipeline-ocata-rpe/ http://tinyurl.com/onobvuq Astellas TO successful @ $8.50, 01/20 |
||||||||||
| SBUX | Starbucks Corp. | 79.15 | 2.76 | 3.61% | 03/04/2016 | |||||
|
My SBUX Pitch: Our split-adjusted bases:$2.19 and $2.984.I look forward to its continued global expansion, particularly in Europe, China, Vietnam, Italy and India. Founder Howard Schultz has led turn-around in U.S. Recent earnings and developments: https://news.starbucks.com/
|
||||||||||
| CPRX | Catalyst Pharmaceutical Partners | 7.03 | 0.02 | 0.29% | 09/02/2014 | |||||
|
My CPRX Pitch: http://tinyurl.com/o6guvhe
|
||||||||||
| AMLN | Amylin Pharmaceuticals Inc. | 08/28/2012 | ||||||||
|
My AMLN Pitch: One of leading T2Diabetes and obesity-focused companies. Underwent takeover examination by >5 companies [AZN,NVS,BMY,SNY,MRK], reported bids >$25/share. BMY/AZN TO @$31/share expired 08/07. I accumulated in many tranches since 1995; basis for 85% of holdings is $6.60/share. Shares now gone @$31.
|
||||||||||
| SGEN | Seattle Genetics | 180.11 | 3.17 | 1.79% | 06/14/2012 | |||||
|
My SGEN Pitch: http://finance.yahoo.com/news/seattle-genetics-highlights-updated-survival-110000422.html
Our basis is $6.30. |
||||||||||
| IBM | International Business Machines | 141.11 | -0.08 | -0.06% | 01/24/2012 | |||||
| JNJ | Johnson&Johnson | 179.26 | 1.75 | 0.99% | 08/12/2010 | |||||
| INSM | INSMED | 20.89 | 1.17 | 5.93% | 08/12/2010 | |||||
